In the study, 78 percent of patients who received BLINCYTO experienced a complete MRD response , a measure of eradication of residual disease at the molecular level, after one treatment cycle. Nearly all complete responses occurred within the first treatment cycle.
http://ift.tt/15VwJ0L
http://ift.tt/15VwJ0L
No comments:
Post a Comment